Travere Therapeutics, Inc. (TVTX)
NASDAQ·Healthcare·Biotechnology
$56.18
+0.39%
Mkt Cap $5.26B
Analyst Ratings
Buy
20
Hold
1
Sell
0
Price Target (21 analysts)
$60.33
Range $49.00 – $67.00
Implied Upside
+7.4%
Consensus $60.33 vs current $56.18
NASDAQ·Healthcare·Biotechnology
$56.18
+0.39%
Mkt Cap $5.26B
Buy
20
Hold
1
Sell
0
Price Target (21 analysts)
$60.33
Range $49.00 – $67.00
+7.4%
Consensus $60.33 vs current $56.18